Site advantages

FMP-Labor

Excellent research, maximum and specialized health care, a knowledge-based economy and multifaceted education and training in the healthcare industry are distinguishing features of Buch. With its clear focus on biomedicine, the health location has outstanding innovation and growth potential. Berlin-Buch has been designated as a premier location for future development in the innovation strategy of the capital city region.

There basic and clinical researchers from academia and non-university institutions are closely interlinked, as are the hospitals, and biotech companies and medical technology companies. Altogether, as key employers in Berlin-Buch, they employ nearly 6,500 people in the health sector. In addition, the health location Berlin-Buch generates an annual value of 320 million euros plus an additional 227 million euros in demand effects in Berlin. As a consequence, over 7,500 jobs have been created in Berlin, resulting in tax revenues for Berlin of 13 million euros per year *.

Thanks to the public funding by the Federal Government and the State of Berlin amounting to 700 million euros*, the research campus in Berlin-Buch has an excellent scientific infrastructure, state-of-the art technology platforms and a biotech park with around 75 companies. The renown of the science and health location attracts world-class scientists and is a magnet for new companies and enterprises.

This has meant that in recent years substantial private investments of 827 million euros have been invested in the region**. The HELIOS Kliniken group has established a maximum-care hospital in Buch and has invested 336 million euros** for this purpose. Thanks to the commitment of companies such as UKB Denkmal AG, COMBAG AG, Ludwig Hoffmann Quartier Objektgesellschaft mbH & Co. KG and the Widerker Group, historic hospital properties have been converted into attractive residential parks. Moreover, a shopping mall, the Schlosspark-Passage has been built in the center of Buch. Companies of the BiotechPark have attracted private investments, including hundreds of millions of euros in venture capital.

Significant economic effects for Berlin through planned investments at the future location Berlin-Buch

Investments of 729 million euros are planned for the healthcare location by 2035, primarily in the structural expansion of the science and biotech campus. This could create 3,800 additional jobs at the Buch site, including 1,275 jobs in biotechnology and medical technology. The gross domestic product could increase by 1.44 billion euros as a result of these investments, and Berlin could generate additional public revenue of around 125 million euros.***


*Up to and including 2024
**Up to and including 2018
***Source: Study by Investionsbank Berlin “Berlin aktuell - Wirtschaftliche Impulse des Zukunftsortes Berlin-Buch”


Nine good reasons for settling on Campus Berlin-Buch

  • Premier capital city location
  • Immediate availability of space
  • Specialized labor force
  • Excellent research centers and hospitals on the campus
  • Attractive rental terms
  • Staff development and in-service training on-site
  • Vibrant and cosmopolitan Campus community
  • Interdisciplinary networks and platforms with uncomplicated access
  • Increasing attractiveness of Berlin-Buch as place to live for Campus employees

News Buch Berlin

A potential new drug for stiff hearts

Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure characterized by impaired cardiac filling. In “Cardiovascular Research,” hi...

more ...

Volker Haucke receives the Ernst Schering Prize 2025

The Ernst Schering Prize 2025, endowed with 50.000 euros, is awarded to Prof. Dr. Volker Haucke, Director at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Professor of Molecula...

more ...

Eckert & Ziegler Gains Approval for GalliaPharm® in Japan

Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), a leading provider of isotope technology for nuclear medicine and radiopharmaceutical applications, has received marketing authorization in Japan ...

more ...

Events Buch Berlin

30.10.2025, 17:00
Talk im Cube: CROs IN DIAGNOSTICS AND THERAPEUTICS DEVELOPMENT

We continue the Talks in the Cube with another expert discussion – the last event for 2025 focusses on Strategies to optimize the cooperation between the sponsor and Contract Research Organizations (C...

more ...

04.11.2025, 16:00
Kryo-Elektronenmikroskopie: Tiefgekühlte Proben ermöglichen das Verständnis biologischer Mechanismen

Vorlesungsreihe: Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch. Für Lehrkräfte, Schülerinnen und Schüler sowie Interessierte.

more ...

05.11.2025, 14:00
Einladung zur Vorlesung: Neurobiologie - Forschung und neue Therapieansätze

Fortbildungsveranstaltung der Neurowissenschaftlichen Gesellschaft e.V. im Rahmen der Vorlesungsreihe: Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch

more ...

This website is supported by: